Cyclophilin B interacts with sodium-potassium ATPase and is required for pump activity in proximal tubule cells of the kidney

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Suñé, Guillermo ^a   Sarró, Eduard ^a   Puigmulé, Marta ^a   López Hellín, Joan ^a   Zufferey, Madeleine ^c   Pertel, Thomas ^c   Luban, Jeremy ^c   Meseguer, Anna ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); COMPLEMENTARY DNA; CYCLOPHILIN B; CYCLOSPORIN A; ATP1B1 PROTEIN, HUMAN; CYCLOPHILIN; CYCLOSPORIN; ENZYME INHIBITOR; PROTEIN SUBUNIT;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; ION TRANSPORT; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE FUNCTION; MEMBRANE CURRENT; MOLECULAR MECHANICS; NEPHROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; ANIMAL; CELL LINE; CELL STRAIN COS1; CELL STRAIN HEK293; CERCOPITHECUS; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TWO HYBRID SYSTEM; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TRANSFORMED; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLOPHILINS; CYCLOSPORINE; ENZYME INHIBITORS; HEK293 CELLS; HUMANS; KIDNEY TUBULES, PROXIMAL; PROTEIN BINDING; PROTEIN SUBUNITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SODIUM-POTASSIUM-EXCHANGING ATPASE; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 78649731916     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013930     Document Type: Article

References (47)

1. Borel JF (1990) Pharmacology of cyclosporine (sandimmune). IV. Pharmacological properties in vivo. Pharmacol Rev 41: 259-371.
2. Blair JT, Thomson AW, Whiting PH, Davidson RJ, Simpson JG (1982) Toxicity of the immune suppressant cyclosporin A in the rat. J Pathol 138: 163-178.
3. Bobadilla NA, Gamba G (2007) New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone. Am J Physiol Renal Physiol 293: F2-F9.
4. Sutherland DE, Strand M, Fryd DS, Ferguson RM, Simmons RL, et al. (1984) Comparison of azathioprine-antilymphocyte globulin versus cyclosporine in renal transplantation. Am J Kidney Dis 3: 456-461.
5. Batlle DC, Gutterman C, Tarka J, Prasad R (1986) Effect of short-term cyclosporine A administration on urinary acidification. Clin Nephrol 25(Suppl 1): S62-69.
6. Capasso G, Rosati C, Ciani F, Giordano DR, Russo F, et al. (1990) The beneficial effect of atrial natriuretic peptide on cyclosporine nephrotoxicity. Am J Hypertens 3: 204-210.
7. Marks AR (1996) Cellular functions of immunophilins. Physiol Rev 76: 631-649.
8. Braaten D, Luban J (2001) Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells. EMBO J 20: 1300-1309.
9. Waldmeier PC, Zimmermann K, Qian T, Tintelnot-Blomley M, Lemasters JJ (2003) Cyclophilin D as a drug target. Curr Med Chem 10: 1485-1506.
10. Handschumacher RE, Harding MW, Rice J, Drugge RJ, Speicher DW (1984) Cyclophilin: A specific cytosolic binding protein for cyclosporin A. Science 226: 544-547.
11. Price ER, Zydowsky LD, Jin MJ, Baker CH, McKeon FD, et al. (1991) Human cyclophilin b: A second cyclophilin gene encodes a peptidyl-prolyl isomerase with a signal sequence. Proc Natl Acad Sci U S A 88: 1903-1907.
12. Tumlin JA, Sands JM (1993) Nephron segment-specific inhibition of Na/K-ATPase activity by cyclosporin a. Kidney Int 43: 246-251.
13. Taylor P, Husi H, Kontopidis G, Walkinshaw MD (1997) Structures of cyclophilin-ligand complexes. Prog Biophys Mol Biol 67: 155-181.
14. Streblow DN, Kitabwalla M, Malkovsky M, Pauza CD (1998) Cyclophilin A modulates processing of human immunodeficiency virus type 1 p55gag: Mechanism for antiviral effects of cyclosporin A. Virology 245: 197-202.
15. Price ER, Jin M, Lim D, Pati S, Walsh CT, et al. (1994) Cyclophilin B trafficking through the secretory pathway is altered by binding of cyclosporin A. Proc Natl Acad Sci U S A 91: 3931-3935.
16. Meunier L, Usherwood YK, Chung KT, Hendershot LM (2002) A subset of chaperones and folding enzymes form multiprotein complexes in endoplasmic reticulum to bind nascent proteins. Mol Biol Cell 12: 4456-4469.
17. Kim J, Choi TG, Ding Y, Kim Y, Ha KS, et al. (2008) Overexpressed cyclophilin B suppresses apoptosis associated with ROS and Ca2+ homeostasis after ER stress. J Cell Sci 121: 3636-3648.
18. Lingrel JB, Kuntzweiler T (1994) Na+,K(+)-ATPase. J Biol Chem 269: 19659-19662.
19. Kaplan JH (2002) Biochemistry of Na/K-ATPase. Annu Rev Biochem 71: 511-535.
20. Suzuki S, Oka T, Ohkuma O, Kuriyama K (1987) Biochemical Mechanisms Underlying Cyclosporine-Induced Nephrotoxicity Effect of Concomitant Administration of Prednisolone. Transplantation 44: 363-368.
21. Kamel KS, Ethier JH, Quaggin S, Levin A, Albert S, et al. (1992) Studies to determine the basis for hyperkalemia in recipients of a renal transplant who are treated with cyclosporine. J Am Soc Nephrol 2: 1279-1284.
22. Skou JC (1990) The fourth datta lecture. The energy coupled exchange of Na+ for K+ across the cell membrane. The Na+, K(+)-pump. FEBS Lett 268: 314-324.
23. Lea JP, Sands JM, McMahon SJ, Tumlin JA (1994) Evidence that the inhibition of Na/K-ATPase activity by FK506 involves calcineurin. Kidney Int 46: 647-652.
24. Baer PC, Tunn UW, Nunez G, Scherberich JE, Geiger H (1999) Transdiffer-entiation of distal but not proximal tubular epithelial cells from human kidney in culture. Exp Nephrol 7(4): 306-13.
25. Ominato M, Satoh T, Katz AI (1996) Regulation of Na/K-ATPase activity in the proximal tubule. Role of the protein kinase c pathway and of eicosanoids. J Membr Biol 152: 235-243.
26. Seki T, Ishimoto T, Sakurai T, Yasuda Y, Taniguchi K, et al. (2005) Increased excretion of urinary 20-HETE in rats with cyclosporine-induced nephrotoxicity. J Pharmacol Sci 97: 132-137.
27. Oriji GK, Keiser HR (1999) Nitric oxide in cyclosporine A-induced hypertension: role of protein kinase C. Am J Hypertens 12(11 Pt 1): 1091-7.
28. Chibalin AV, Katz AI, Berggren PO, Bertorello AM (1997) Receptor-mediated inhibition of renal Na(+)-K(+)-ATPase is associated with endocytosis of its alpha-and beta-subunits. Am J Physiol 273: 1458-1465.
29. Geering K, Beggah A, Good P, Girardet S, Roy S, et al. (1996) Oligomerization and maturation of Na/K-ATPase. Functional interaction of the cytoplasmic NH2 terminus of the beta subunit with the alpha subunit. J Cell Biol 133: 1193-1204.
30. Geering K, Theulaz I, Verrey F, Hauptle MT, Rossier BC (1989) A role for the beta-subunit in the expression of functional Na/K-ATPase in xenopus oocytes. Am J Physiol 257: C851-858.
31. Ueno S, Takeda K, Noguchi S, Kawamura M (1997) Significance of the beta-subunit in the biogenesis of Na/K-ATPase. Biosci Rep 17: 173-188.
32. Stabach PR, Devarajan P, Stankewich MC, Bannykh S, Morrow JS (2008) Ankyrin facilitates intracellular trafficking of alpha1-Na+-K+-ATPase in polarized cells. Am J Physiol Cell Physiol 295: 1202-1214.
33. Baldridge D, Lennington J, Weis M, Homan EP, Jiang MM, et al. (2010) Generalized connective tissue disease in Crtap-/- mouse. PLoS One 5(5): e10560.
34. Morello R, Bertin TK, Chen Y, Hicks J, Tonachini L, et al. (2006) CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 127(2): 291-304.
35. Morello R, Bertin TK, Chen Y, Hicks J, Tonachini L, et al. (2007) Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta. Nat Genet 39(3): 359-65.
36. Fang F, Flegler AJ, Du P, Lin S, Clevenger CV (2009) Expression of cyclophilin B is associated with malignant progression and regulation of genes implicated in the pathogenesis of breast cancer. Am J Pathol 174(1): 297-308.
37. Hanoulle X, Melchior A, Sibille N, Parent B, Denys A, et al. (2007) Structural and functional characterization of the interaction between cyclophilin B and a heparin-derived oligosaccharide. J Biol Chem 282(47): 34148-58.
38. Yurchenko V, Constant S, Eisenmesser E, Bukrinsky M (2010) Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics. Clin Exp Immunol 2010 Jun;160(3): 305-17.
39. Espineda CE, Chang JH, Twiss J, Rajasekaran SA, Rajasekaran AK (2004) Repression of Na/K-ATPase beta1-subunit by the transcription factor snail in carcinoma. Mol Biol Cell 15: 1364-1373.
40. Rajasekaran AK, Gopal J, Rajasekaran SA (2003) Na/K-ATPase in the regulation of epithelial cell structure. Ann N Y Acad Sci 986: 649-651.
41. Rajasekaran SA, Rajasekaran AK (2009) Na/K-ATPase and epithelial tight junctions. Front Biosci 14: 2130-2148.
42. Chen Y, Cai T, Wang H, Li Z, Loreaux E, et al. (2009) Regulation of intracellular cholesterol distribution by Na/K-ATPase. J Biol Chem 284: 14881-14890.
43. Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, et al. (1994) HK-2: An immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 45: 48-57.
44. Puigmule M, Lopez-Hellin J, Sune G, Tornavaca O, Camano S, et al. (2009) Differential proteomic analysis of cyclosporine A-induced toxicity in renal proximal tubule cells. Nephrol Dial Transplant 24: 2672-2686.
45. Sarró E, Tornavaca O, Plana M, Meseguer A, Itarte E (2008) Phosphoinositide 3-kinase inhibitors protect mouse kidney cells from cyclosporine-induced cell death. Kidney Int 73(1): 77-85.
46. Healy E, Dempsey M, Lally C, Ryan MP (1998) Apoptosis and necrosis: mechanisms of cell death induced by cyclosporine A in a renal proximal tubular cell line. Kidney Int 54(6): 1955-66.
47. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.